Information for activists, patients, health workers & researchers working to end tuberculosis
Website of the Global Tuberculosis Community Advisory Board
By Andrea S. Blevins Primeau, PhD, MBA Published: Jan. 25, 2024, 3:26 p.m.· Tags: Latent TB
Immune checkpoint inhibitor (ICI) treatment may increase the risk of tuberculosis reactivation or latent tuberculosis infection in patients with cancer, according to research published in The Oncologist.
Read More →
Page 1 of 1 · Total posts: 1
